Procter & Gamble Company (PG) reported $87.92B of revenue for the twelve months ended Sep 30, 2026. That is up 3.5% from the year before. Revenue for fiscal 2026 was $87.03B.

Yes. Procter & Gamble Company earned $16.03B in net income for the twelve months ended Sep 30, 2026, a net margin of 18.2%.

How much cash and debt does PG have?

Procter & Gamble Company reported $15.37B in cash and cash equivalents and $38.92B of debt on its most recent balance sheet in SEC filings.

How fast is PG revenue growing?

Procter & Gamble Company's revenue changed +3.3% in fiscal 2026, to $87.03B. Its compound annual growth rate was +2.7% over 5 years and +2.9% over 10 years.

What is PG gross margin?

Procter & Gamble Company's gross profit was $43.77B on $87.92B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 49.8%.

What is PG free cash flow?

Procter & Gamble Company generated $15.34B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $19.91B less capital expenditures.

What is PG earnings per share?

Diluted earnings per share were $6.64 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did PG last report financial results?

The latest statements here come from Procter & Gamble Company's 10-Q filed on Oct 22, 2026, covering the period ended Sep 30, 2026.

Where does this PG financial data come from?

Quantisnow builds these statements from the structured XBRL data Procter & Gamble Company files with the SEC. It is provided for information only and is not investment advice.

Financials · PG

Procter & Gamble Company (PG) financials

For the twelve months ended Sep 30, 2026, Procter & Gamble Company reported $87.92B of revenue and $16.03B of net income.

Revenue, TTM: $87.92B
Revenue growth, YoY: +3.5%
Net income, TTM: $16.03B
Net income growth, YoY: -4.4%
Net margin: 18.2%
Free cash flow, TTM: $15.34B
EPS, diluted, TTM: $6.64
EPS growth, YoY: -3.1%
Cash: $15.37B
Total debt: $38.92B
P/E: 24.34
P/S: 4.44
Market cap: $390.13B

Annual revenue$87.03B

FY2017FY2026

Annual net income$16.05B

FY2017FY2026

Annual free cash flow$15.15B

FY2017FY2026

PG revenue and earnings growth

PG revenueQ1 2027$23.28B

Quarter YoY: +4.0%
QoQ: +9.8%
FY YoY: +3.3%
5Y CAGR: +2.7%
10Y CAGR: +2.9%

PG revenue was $23.28B in fiscal Q1 2027 (ended Sep 30, 2026), up 4.0% from a year earlier and up 9.8% from the prior quarter. For the full fiscal 2026 it was $87.03B, up 3.3% from fiscal 2025. Compound annual growth was +2.7% over 5 years and +2.9% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2026 is the highest of the 15 fiscal years on file.

PG net incomeQ1 2027$4.73B

Quarter YoY: -0.4%
QoQ: +55.4%
FY YoY: +0.5%
5Y CAGR: +2.3%
10Y CAGR: +4.3%

PG net income was $4.73B in fiscal Q1 2027 (ended Sep 30, 2026), down 0.4% from a year earlier and up 55.4% from the prior quarter. For the full fiscal 2026 it was $16.05B, up 0.5% from fiscal 2025. Compound annual growth was +2.3% over 5 years and +4.3% over 10 years. It rose in 7 of the last 10 fiscal years. Fiscal 2026 is the highest of the 15 fiscal years on file.

PG EPSQ1 2027$1.97

Quarter YoY: +1.0%
QoQ: +56.3%
FY YoY: +1.7%
5Y CAGR: +3.8%
10Y CAGR: +6.0%

PG diluted EPS was $1.97 in fiscal Q1 2027 (ended Sep 30, 2026), up 1.0% from a year earlier and up 56.3% from the prior quarter. For the full fiscal 2026 it was $6.62, up 1.7% from fiscal 2025. Compound annual growth was +3.8% over 5 years and +6.0% over 10 years.

PG free cash flowQ1 2027$4.40B

Quarter YoY: +4.6%
QoQ: +7.1%
FY YoY: +7.9%
5Y CAGR: -0.6%
10Y CAGR: +2.3%

PG free cash flow was $4.40B in fiscal Q1 2027 (ended Sep 30, 2026), up 4.6% from a year earlier and up 7.1% from the prior quarter. For the full fiscal 2026 it was $15.15B, up 7.9% from fiscal 2025. Compound annual growth was -0.6% over 5 years and +2.3% over 10 years. It rose in 7 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2026 Jun 30, 2026	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017
Revenue	$87.03B	$84.28B	$84.04B	$82.01B	$80.19B	$76.12B	$70.95B	$67.68B	$66.83B	$65.06B
Cost of revenue	$43.36B	$41.16B	$40.85B	$42.76B	$42.16B	$37.11B	$35.25B	$34.77B	$34.43B	$32.64B
Gross profit	$43.67B	$43.12B	$43.19B	$39.25B	$38.03B	$39.01B	$35.70B	$32.92B	$32.40B	$32.42B
Research and development	$2.10B	$2.10B	$2.00B	$2.00B	$2.00B	$1.90B	$1.80B	$1.90B	$1.90B	$1.90B
Selling, general and admin	$23.92B	$22.67B	$23.30B	$21.11B	$20.22B	$21.02B	$19.99B	$19.08B	$19.04B	$18.65B
Operating income	$19.75B	$20.45B	$18.55B	$18.13B	$17.81B	$17.99B	$15.71B	$5.49B	$13.36B	$13.77B
Interest expense	$877.00M	$907.00M	$925.00M	$756.00M	$439.00M	$502.00M	$465.00M	$509.00M	$506.00M	$465.00M
Pre-tax income	$20.38B	$20.17B	$18.76B	$18.35B	$18.00B	-	-	-	-	-
Income tax	$4.23B	$4.10B	$3.79B	$3.62B	$3.20B	$3.26B	$2.73B	$2.10B	$3.46B	$3.06B
Net income	$16.05B	$15.97B	$14.88B	$14.65B	$14.74B	$14.31B	$13.03B	$3.90B	$9.75B	$15.33B
EPS, basic	$6.75	$6.67	$6.18	$6.07	$6.00	$5.69	$5.13	$1.45	$3.75	$5.80
EPS, diluted	$6.62	$6.51	$6.02	$5.90	$5.81	$5.50	$4.96	$1.43	$3.67	$5.59
Diluted shares	2.42B	2.45B	2.47B	2.48B	2.54B	2.60B	2.63B	2.54B	2.66B	2.74B

Balance sheet

Balance sheet
Line item	FY2026 Jun 30, 2026	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017
Cash and equivalents	$9.94B	$9.56B	$9.48B	$8.25B	$7.21B	$10.29B	$16.18B	$4.24B	$2.57B	$5.57B
Receivables	$6.06B	$6.18B	$6.12B	$5.47B	$5.14B	$4.72B	$4.18B	$4.95B	$4.69B	$4.59B
Inventory	$8.17B	$7.55B	$7.02B	$7.07B	$6.92B	$5.98B	$5.50B	$5.02B	$4.74B	$4.62B
Current assets	$26.21B	$25.39B	$24.71B	$22.65B	$21.65B	$23.09B	$27.99B	$22.47B	$23.32B	$26.49B
Goodwill	$41.28B	$41.65B	$40.30B	$40.66B	$39.70B	$40.92B	$39.90B	$40.27B	$45.17B	$44.70B
Total assets	$126.52B	$125.23B	$122.37B	$120.83B	$117.21B	$119.31B	$120.70B	$115.09B	$118.31B	$120.41B
Current liabilities	$38.69B	$36.06B	$33.63B	$35.76B	$33.08B	$33.13B	$32.98B	$30.01B	$28.24B	$30.21B
Short-term debt	$11.30B	$9.51B	$7.19B	$10.23B	$8.64B	$8.89B	$11.18B	$9.70B	$10.42B	$13.55B
Long-term debt	$22.84B	$25.00B	$25.27B	$24.38B	$22.85B	$23.10B	$23.54B	$20.39B	$20.86B	$18.04B
Total debt	$34.14B	$34.51B	$32.46B	$34.61B	$31.49B	$31.99B	$34.72B	$30.09B	$31.29B	$31.59B
Total liabilities	$72.21B	$72.95B	$71.81B	$73.76B	$70.35B	$72.65B	$73.82B	$67.52B	$65.43B	$64.63B
Shareholders' equity	$54.31B	$52.28B	$50.56B	$47.06B	$46.85B	$46.65B	$46.88B	$47.58B	$52.88B	$55.78B

Cash flow

Cash flow
Line item	FY2026 Jun 30, 2026	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017
Operating cash flow	$19.56B	$17.82B	$19.85B	$16.85B	$16.72B	$18.37B	$17.40B	$15.24B	$14.87B	$12.75B
Capital expenditures	$4.41B	$3.77B	$3.32B	$3.06B	$3.16B	$2.79B	$3.07B	$3.35B	$3.72B	$3.38B
Free cash flow	$15.15B	$14.04B	$16.52B	$13.79B	$13.57B	$15.58B	$14.33B	$11.89B	$11.15B	$9.37B
Investing cash flow	-$4.62B	-$3.82B	-$3.50B	-$3.50B	-$4.42B	-$2.83B	$3.04B	-$3.49B	-$3.51B	-$6.68B
Financing cash flow	-$14.46B	-$14.04B	-$14.86B	-$12.15B	-$14.88B	-$21.53B	-$8.37B	-$9.99B	-$14.38B	-$8.57B
Dividends paid	$10.23B	$9.87B	$9.31B	$9.00B	$8.77B	$8.26B	$7.79B	$7.50B	$7.31B	$7.24B
Share repurchases	$5.03B	$6.50B	$5.01B	$7.35B	$10.00B	$11.01B	$7.41B	$5.00B	$7.00B	$5.20B
Stock-based compensation	$524.00M	$476.00M	$562.00M	$545.00M	$528.00M	$540.00M	$558.00M	$515.00M	$395.00M	$351.00M
Depreciation and amortization	$3.16B	$2.85B	$2.90B	$2.71B	$2.81B	$2.73B	$3.01B	$2.82B	$2.83B	$2.82B

Key ratios

Key ratios
Line item	FY2026 Jun 30, 2026	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017
Revenue growth, YoY	3.3%	0.3%	2.5%	2.3%	5.3%	7.3%	4.8%	1.3%	2.7%	-0.4%
Net income growth, YoY	0.5%	7.4%	1.5%	-0.6%	3.0%	9.8%	234.3%	-60.0%	-36.4%	45.9%
EPS growth, YoY	1.7%	8.1%	2.0%	1.5%	5.6%	10.9%	246.9%	-61.0%	-34.3%	51.5%
Gross margin	50.2%	51.2%	51.4%	47.9%	47.4%	51.2%	50.3%	48.6%	48.5%	49.8%
Operating margin	22.7%	24.3%	22.1%	22.1%	22.2%	23.6%	22.1%	8.1%	20.0%	21.2%
Net margin	18.4%	19.0%	17.7%	17.9%	18.4%	18.8%	18.4%	5.8%	14.6%	23.6%
Free cash flow margin	17.4%	16.7%	19.7%	16.8%	16.9%	20.5%	20.2%	17.6%	16.7%	14.4%
Return on equity	29.5%	30.6%	29.4%	31.1%	31.5%	30.7%	27.8%	8.2%	18.4%	27.5%
Return on assets	12.7%	12.8%	12.2%	12.1%	12.6%	12.0%	10.8%	3.4%	8.2%	12.7%
Current ratio	0.68	0.70	0.73	0.63	0.65	0.70	0.85	0.75	0.83	0.88
Debt to equity	0.63	0.66	0.64	0.74	0.67	0.69	0.74	0.63	0.59	0.57

Income statement

Income statement
Line item	Q1 2027 Sep 30, 2026	Q4 2026* Jun 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023
Revenue	$23.28B	$21.20B	$21.23B	$22.21B	$22.39B	$20.89B	$19.78B	$21.88B	$21.74B	$20.53B	$20.20B	$21.44B
Cost of revenue	$11.68B	$10.92B	$10.72B	$10.83B	$10.89B	$10.63B	$9.69B	$10.42B	$10.42B	$10.35B	$9.86B	$10.14B
Gross profit	$11.60B	$10.28B	$10.51B	$11.37B	$11.50B	$10.26B	$10.08B	$11.46B	$11.32B	$10.18B	$10.34B	$11.30B
Selling, general and admin	$5.66B	$6.33B	$5.94B	$6.01B	$5.64B	$5.90B	$5.52B	$5.72B	$5.52B	$6.30B	$5.88B	$5.52B
Operating income	$5.94B	$3.95B	$4.58B	$5.37B	$5.86B	$4.36B	$4.56B	$5.74B	$5.80B	$3.88B	$4.46B	$4.43B
Interest expense	$223.00M	$236.00M	$223.00M	$220.00M	$197.00M	$212.00M	$217.00M	$240.00M	$238.00M	$220.00M	$233.00M	$248.00M
Income tax	$1.27B	$852.00M	$1.04B	$1.09B	$1.25B	$895.00M	$868.00M	$1.19B	$1.15B	$726.00M	$812.00M	$1.00B
Net income	$4.73B	$3.04B	$3.93B	$4.32B	$4.75B	$3.62B	$3.77B	$4.63B	$3.96B	$3.14B	$3.75B	$3.47B
EPS, basic	$2.00	$1.27	$1.66	$1.82	$2.00	$1.50	$1.58	$1.94	$1.65	$1.29	$1.56	$1.44
EPS, diluted	$1.97	$1.26	$1.63	$1.78	$1.95	$1.48	$1.54	$1.88	$1.61	$1.27	$1.52	$1.40
Diluted shares	2.41B	-	2.42B	2.42B	2.44B	-	2.45B	2.46B	2.47B	-	2.47B	2.47B

Balance sheet

Balance sheet
Line item	Q1 2027 Sep 30, 2026	Q4 2026* Jun 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023
Cash and equivalents	$15.37B	$9.94B	$12.31B	$10.82B	$11.17B	$9.56B	$9.12B	$10.23B	$12.16B	$9.48B	$6.83B	$7.89B
Receivables	$6.62B	$6.06B	$6.32B	$6.28B	$6.49B	$6.18B	$6.14B	$6.23B	$6.31B	$6.12B	$6.12B	$6.33B
Inventory	$8.48B	$8.17B	$7.85B	$7.82B	$7.85B	$7.55B	$7.40B	$7.02B	$7.29B	$7.02B	$7.08B	$7.15B
Current assets	$32.51B	$26.21B	$27.99B	$26.59B	$27.12B	$25.39B	$24.43B	$25.64B	$27.45B	$24.71B	$22.46B	$23.11B
Goodwill	$41.20B	$41.28B	$41.36B	$41.66B	$41.64B	$41.65B	$40.48B	$39.90B	$40.97B	$40.30B	$40.57B	$40.92B
Total assets	$133.13B	$126.52B	$128.38B	$127.29B	$127.60B	$125.23B	$122.98B	$122.64B	$126.48B	$122.37B	$119.60B	$120.71B
Current liabilities	$45.00B	$38.69B	$38.23B	$36.70B	$37.99B	$36.06B	$34.25B	$33.80B	$36.42B	$33.63B	$32.34B	$35.95B
Short-term debt	$17.03B	$11.30B	$13.17B	$11.06B	$11.63B	$9.51B	$9.89B	$9.42B	$10.41B	$7.19B	$7.73B	$10.62B
Long-term debt	$21.90B	$22.84B	$23.85B	$25.58B	$24.32B	$25.00B	$24.25B	$25.26B	$25.74B	$25.27B	$24.25B	$23.10B
Total debt	$38.92B	$34.14B	$37.03B	$36.64B	$35.95B	$34.51B	$34.14B	$34.69B	$36.15B	$32.46B	$31.98B	$33.71B
Total liabilities	$77.80B	$72.21B	$73.65B	$73.97B	$74.05B	$72.95B	$70.44B	$71.19B	$74.34B	$71.81B	$69.26B	$71.88B
Shareholders' equity	$55.34B	$54.31B	$54.73B	$53.32B	$53.55B	$52.28B	$52.55B	$51.44B	$52.14B	$50.56B	$50.33B	$48.83B

Cash flow

Cash flow
Line item	Q1 2027 Sep 30, 2026	Q4 2026* Jun 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023
Operating cash flow	$5.77B	$5.13B	$4.04B	$4.97B	$5.41B	$4.99B	$3.71B	$4.83B	$4.30B	$5.75B	$4.09B	$5.10B
Capital expenditures	$1.37B	$1.02B	$1.02B	$1.17B	$1.20B	$996.00M	$859.00M	$925.00M	$993.00M	$783.00M	$797.00M	$817.00M
Free cash flow	$4.40B	$4.11B	$3.03B	$3.81B	$4.21B	$3.99B	$2.85B	$3.90B	$3.31B	$4.97B	$3.29B	$4.28B
Investing cash flow	-$1.46B	-$1.20B	-$665.00M	-$1.23B	-$1.53B	-$1.06B	-$726.00M	-$921.00M	-$1.11B	-$518.00M	-$762.00M	-$1.00B
Financing cash flow	$1.14B	-$6.31B	-$1.83B	-$4.09B	-$2.24B	-$3.62B	-$4.21B	-$5.57B	-$634.00M	-$2.50B	-$4.27B	-$6.05B
Dividends paid	$2.60B	$2.61B	$2.53B	$2.54B	$2.55B	$2.55B	$2.43B	$2.44B	$2.44B	$2.45B	$2.29B	$2.29B
Share repurchases	$1.25B	$875.00M	$625.00M	$2.28B	$1.25B	$700.00M	$1.35B	$2.51B	$1.94B	$1.52B	$987.00M	$1.00B
Stock-based compensation	$98.00M	$130.00M	$132.00M	$141.00M	$121.00M	$112.00M	$123.00M	$136.00M	$105.00M	$129.00M	$158.00M	$150.00M
Depreciation and amortization	$810.00M	$812.00M	$785.00M	$803.00M	$761.00M	$723.00M	$690.00M	$706.00M	$728.00M	$761.00M	$712.00M	$721.00M

Key ratios

Key ratios
Line item	Q1 2027 Sep 30, 2026	Q4 2026* Jun 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023
Revenue growth, YoY	4.0%	1.5%	7.4%	1.5%	3.0%	1.7%	-2.1%	2.1%	-0.6%	-0.1%	0.6%	3.2%
Net income growth, YoY	-0.4%	-15.8%	4.3%	-6.7%	20.0%	15.2%	0.4%	33.5%	-12.4%	-7.3%	10.5%	-11.8%
EPS growth, YoY	1.0%	-14.9%	5.8%	-5.3%	21.1%	16.5%	1.3%	34.3%	-12.0%	-7.3%	10.9%	-11.9%
Gross margin	49.8%	48.5%	49.5%	51.2%	51.4%	49.1%	51.0%	52.4%	52.1%	49.6%	51.2%	52.7%
Operating margin	25.5%	18.6%	21.5%	24.2%	26.2%	20.8%	23.0%	26.2%	26.7%	18.9%	22.1%	20.7%
Net margin	20.3%	14.4%	18.5%	19.4%	21.2%	17.3%	19.1%	21.2%	18.2%	15.3%	18.6%	16.2%
Free cash flow margin	18.9%	19.4%	14.3%	17.1%	18.8%	19.1%	14.4%	17.8%	15.2%	24.2%	16.3%	20.0%
Current ratio	0.72	0.68	0.73	0.72	0.71	0.70	0.71	0.76	0.75	0.73	0.69	0.64
Debt to equity	0.70	0.63	0.68	0.69	0.67	0.66	0.65	0.67	0.69	0.64	0.64	0.69

Source: XBRL data Procter & Gamble Company files with the SEC, latest filing dated Oct 22, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

PG peers

Company	Revenue	Growth	Net income	Net margin	Market cap
PG	$87.92B	+3.5%	$16.03B	18.2%	$390.13B
ULUnilever PLC	€50.50B	-3.8%	€9.47B	18.7%	$143.50B
ECLEcolab Inc.	$17.37B	+9.3%	$2.08B	12.0%	$86.03B
CLColgate-Palmolive Company	$21.28B	+5.9%	$2.05B	9.6%	$77.85B
ELEstee Lauder Companies Inc.	$15.28B	+5.8%	$368.00M	2.4%	$41.00B
HLNHaleon plc	£11.03B	-1.8%	£1.67B	15.1%	$39.43B
KVUEKenvue Inc.	$15.53B	+3.5%	$1.69B	10.9%	$37.57B
CHDChurch & Dwight Company Inc.	$6.25B	+1.7%	$774.80M	12.4%	$26.27B
ELFe.l.f. Beauty Inc.	$1.94B	+39.9%	$86.64M	4.5%	$7.06B

PG FAQ

9 questions

What is PG revenue?
Procter & Gamble Company (PG) reported $87.92B of revenue for the twelve months ended Sep 30, 2026. That is up 3.5% from the year before. Revenue for fiscal 2026 was $87.03B.
Is PG profitable?
Yes. Procter & Gamble Company earned $16.03B in net income for the twelve months ended Sep 30, 2026, a net margin of 18.2%.
How much cash and debt does PG have?
Procter & Gamble Company reported $15.37B in cash and cash equivalents and $38.92B of debt on its most recent balance sheet in SEC filings.
How fast is PG revenue growing?
Procter & Gamble Company's revenue changed +3.3% in fiscal 2026, to $87.03B. Its compound annual growth rate was +2.7% over 5 years and +2.9% over 10 years.
What is PG gross margin?
Procter & Gamble Company's gross profit was $43.77B on $87.92B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 49.8%.
What is PG free cash flow?
Procter & Gamble Company generated $15.34B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $19.91B less capital expenditures.
What is PG earnings per share?
Diluted earnings per share were $6.64 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did PG last report financial results?
The latest statements here come from Procter & Gamble Company's 10-Q filed on Oct 22, 2026, covering the period ended Sep 30, 2026.
Where does this PG financial data come from?
Quantisnow builds these statements from the structured XBRL data Procter & Gamble Company files with the SEC. It is provided for information only and is not investment advice.